Antibody response of infants in tropics to five doses of oral polio vaccine

scientific article published on 01 April 1976

Antibody response of infants in tropics to five doses of oral polio vaccine is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1136/BMJ.1.6013.812
P953full work available at URLhttps://europepmc.org/articles/PMC1639412
https://europepmc.org/articles/PMC1639412?pdf=render
P932PMC publication ID1639412
P698PubMed publication ID1260345

P2093author name stringT. J. John
P2860cites workOral polio vaccination of children in the tropics. I. The poor seroconversion rates and the absence of viral interferenceQ34207204
Oral polio vaccination of children in the tropics. II. Antibody response in relation to vaccine virus infectionQ39108539
Effect of breast-feeding on seroresponse of infants to oral poliovirus vaccinationQ39970102
Paralytic poliomyelitis: clinical and virological studies.Q54105661
P433issue6013
P407language of work or nameEnglishQ1860
P921main subjectvaccineQ134808
polio vaccineQ1519099
P304page(s)812
P577publication date1976-04-01
1976-04-03
P1433published inThe BMJQ546003
P1476titleAntibody response of infants in tropics to five doses of oral polio vaccine
P478volume1

Reverse relations

cites work (P2860)
Q50319723A better system for polio vaccination in developing countries?
Q36147075A spatial model of Wild Poliovirus Type 1 in Kano State, Nigeria: calibration and assessment of elimination probability
Q36675640Antibodies against poliomyelitis and measles viruses in immunized and unimmunized children, Ghana 1976-78.
Q70909156Appropriate strategy for childhood immunization in India. II-The need and purpose of an authoritative immunization schedule
Q36185607Biomarkers of Environmental Enteropathy are Positively Associated with Immune Responses to an Oral Cholera Vaccine in Bangladeshi Children
Q47794110Causes of impaired oral vaccine efficacy in developing countries.
Q91901469Chapter 4 Picornavirus infections
Q36669805Clinical efficacy of trivalent oral poliomyelitis vaccine: a case-control study
Q38594131Early immunization of neonates with trivalent oral poliovirus vaccine
Q37425479Effect of human rotavirus vaccine on severe diarrhea in African infants
Q73749881Effect of passively transferred anti-poliovirus antibodies on seroconversion
Q40045569Effect of pentavalent rotavirus vaccine introduction on hospital admissions for diarrhoea and rotavirus in children in Rwanda: a time-series analysis
Q38879736Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial
Q24633576Eradicating poliomyelitis: India's journey from hyperendemic to polio-free status
Q84955446Escape in four categories
Q36799286Evaluation of a poliomyelitis immunization campaign in Madras city.
Q37636873Evaluation of rotavirus vaccines in Asia--are there lessons to be learnt?
Q30299958Exploring the role of environmental enteropathy in malnutrition, infant development and oral vaccine response
Q37287347Factors determining anti-poliovirus type 3 antibodies among orally immunised Indian infants
Q41879594Immune response of neonates to oral poliomyelitis vaccine.
Q67450389Immunity level against poliomyelitis in a group of children vaccinated according to an official immunization schedule (São Paulo, Brazil)
Q21245322Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccine
Q42201983Immunogenicity of a three dose and five dose oral human rotavirus vaccine (RIX4414) schedule in south Indian infants
Q44772970Impact of annual immunisation programme with oral polio vaccine on the prevalence of paralytic poliomyelitis
Q27024768Insights from global data for use of rotavirus vaccines in India
Q61804344Interventions to improve oral vaccine performance: a systematic review and meta-analysis
Q54204593Lymphoid tissue fibrosis is associated with impaired vaccine responses.
Q33767570Maternal antibodies to rotavirus: could they interfere with live rotavirus vaccines in developing countries?
Q99594866Metagenomic sequencing of stool samples in Bangladeshi infants: virome association with poliovirus shedding after oral poliovirus vaccination
Q44444464OPV cannot eradicate polio from India: do we need any further evidence?
Q39815110Observations on Indian neurology.
Q60920085Oral polio vaccine response in the MAL-ED birth cohort study: Considerations for polio eradication strategies
Q46989673Paralytic poliomyelitis: seasoned strategies, disappearing disease
Q30301148Pediatric small intestine bacterial overgrowth in low-income countries
Q44613483Polio eradication in India: some observations
Q39342391Poliomyelitis outbreak in South Africa, 1982. II. Laboratory and vaccine aspects
Q35923837Probiotics, antibiotics and the immune responses to vaccines.
Q34324987Progress towards global polio eradication
Q47832226Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011-2030.
Q37363974Public health impact and cost effectiveness of mass vaccination with live attenuated human rotavirus vaccine (RIX4414) in India: model based analysis
Q36794380Randomized, controlled trial of trivalent oral poliovirus vaccine (sabin) starting at birth in Ghana
Q68391999Revised immunisation schedule of the WHO expanded programme on immunisation
Q81587066Role of genetic factors in polio eradication: new challenge for policy makers
Q44901258Rotavirus vaccine: current status
Q24595355The anti-vaccination movement and resistance to allergen-immunotherapy: a guide for clinical allergists
Q36876170The efficacy of DPT and oral poliomyelitis immunization schedules initiated from birth to 12 weeks of age.
Q39425504Vaccinology of poliomyelitis
Q80655288What needs to be done for polio eradication in India?
Q37493291Why polio has not been eradicated in India despite many remedial interventions?

Search more.